{"entity":{"type":"insider","cik":"0001534264","url":"/insider/0001534264","json_url":"/insider/0001534264.json","name":"Casdin Eli","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":107,"n_filings":58,"first":"2018-07-23","last":"2026-06-08","span_basis":"filed_date"},"name_variants":[{"name":"Casdin Eli","source":"filing","n_filings":58,"first_seen":"2018-07-23","last_seen":"2026-06-08"}],"transactions":[{"id":6164243,"accession":"0000919574-26-003907","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-26-003907","line_url":"/filing/0000919574-26-003907#line-2","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Eli","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":52.8566,"price_display":"52.86","price_state":"stated","total_value":2642830.0,"total_display":"2,642,830.00","total_whole":"2,642,830","shares_owned_after":3707164.0,"shares_owned_after_display":"3,707,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-05","filed_date":"2026-06-08","scope":"insider"},{"id":6164239,"accession":"0000919574-26-003907","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-26-003907","line_url":"/filing/0000919574-26-003907#line-1","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Eli","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":56.4449,"price_display":"56.44","price_state":"stated","total_value":8466735.0,"total_display":"8,466,735.00","total_whole":"8,466,735","shares_owned_after":3657164.0,"shares_owned_after_display":"3,657,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-08","scope":"insider"},{"id":5937213,"accession":"0000919574-26-003646","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-26-003646","line_url":"/filing/0000919574-26-003646#line-3","is_derivative":false,"issuer_cik":"0000834365","issuer_name":"BIOLIFE SOLUTIONS INC","issuer_ticker":"BLFS","issuer_name_source":null,"issuer_url":"/issuer/0000834365","owner_cik":null,"owner_name":"Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Eli","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650000.0,"shares_display":"650,000","price_per_share":23.7,"price_display":"23.70","price_state":"stated","total_value":15405000.0,"total_display":"15,405,000.00","total_whole":"15,405,000","shares_owned_after":4757165.0,"shares_owned_after_display":"4,757,165","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-21","filed_date":"2026-05-21","scope":"insider"},{"id":6217081,"accession":"0000919574-26-003627","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-26-003627","line_url":"/filing/0000919574-26-003627#line-3","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Eli","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":140000.0,"shares_display":"140,000","price_per_share":43.8061,"price_display":"43.81","price_state":"stated","total_value":6132854.0,"total_display":"6,132,854.00","total_whole":"6,132,854","shares_owned_after":3507164.0,"shares_owned_after_display":"3,507,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-20","scope":"insider"},{"id":5937211,"accession":"0000919574-26-003646","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-26-003646","line_url":"/filing/0000919574-26-003646#line-2","is_derivative":false,"issuer_cik":"0000834365","issuer_name":"BIOLIFE SOLUTIONS INC","issuer_ticker":"BLFS","issuer_name_source":null,"issuer_url":"/issuer/0000834365","owner_cik":null,"owner_name":"Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Eli","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":23.7,"price_display":"23.70","price_state":"stated","total_value":5925000.0,"total_display":"5,925,000.00","total_whole":"5,925,000","shares_owned_after":5407165.0,"shares_owned_after_display":"5,407,165","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-21","scope":"insider"},{"id":6217076,"accession":"0000919574-26-003627","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-26-003627","line_url":"/filing/0000919574-26-003627#line-2","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Eli","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":185000.0,"shares_display":"185,000","price_per_share":42.5964,"price_display":"42.60","price_state":"stated","total_value":7880334.0,"total_display":"7,880,334.00","total_whole":"7,880,334","shares_owned_after":3367164.0,"shares_owned_after_display":"3,367,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-20","scope":"insider"},{"id":5937209,"accession":"0000919574-26-003646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-26-003646","line_url":"/filing/0000919574-26-003646#line-1","is_derivative":false,"issuer_cik":"0000834365","issuer_name":"BIOLIFE SOLUTIONS INC","issuer_ticker":"BLFS","issuer_name_source":null,"issuer_url":"/issuer/0000834365","owner_cik":null,"owner_name":"Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Eli","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":22.65,"price_display":"22.65","price_state":"stated","total_value":6795000.0,"total_display":"6,795,000.00","total_whole":"6,795,000","shares_owned_after":5657165.0,"shares_owned_after_display":"5,657,165","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-21","scope":"insider"},{"id":6217071,"accession":"0000919574-26-003627","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-26-003627","line_url":"/filing/0000919574-26-003627#line-1","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Eli","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175000.0,"shares_display":"175,000","price_per_share":42.5517,"price_display":"42.55","price_state":"stated","total_value":7446547.5,"total_display":"7,446,547.50","total_whole":"7,446,548","shares_owned_after":3182164.0,"shares_owned_after_display":"3,182,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider"},{"id":4295167,"accession":"0000919574-25-007243","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-007243","line_url":"/filing/0000919574-25-007243#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_display_name":"Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":1.4468,"price_display":"1.45","price_state":"stated","total_value":217020.0,"total_display":"217,020.00","total_whole":"217,020","shares_owned_after":72100000.0,"shares_owned_after_display":"72,100,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-04","scope":"insider"},{"id":4295163,"accession":"0000919574-25-007243","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-007243","line_url":"/filing/0000919574-25-007243#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_display_name":"Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":1.4405,"price_display":"1.44","price_state":"stated","total_value":108037.5,"total_display":"108,037.50","total_whole":"108,038","shares_owned_after":71950000.0,"shares_owned_after_display":"71,950,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-04","scope":"insider"},{"id":4295156,"accession":"0000919574-25-007243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-007243","line_url":"/filing/0000919574-25-007243#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_display_name":"Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":1.4201,"price_display":"1.42","price_state":"stated","total_value":177512.5,"total_display":"177,512.50","total_whole":"177,513","shares_owned_after":71875000.0,"shares_owned_after_display":"71,875,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-04","scope":"insider"},{"id":4192710,"accession":"0000919574-25-007187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-007187","line_url":"/filing/0000919574-25-007187#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7550000.0,"shares_display":"7,550,000","price_per_share":1.3031,"price_display":"1.30","price_state":"stated","total_value":9838405.0,"total_display":"9,838,405.00","total_whole":"9,838,405","shares_owned_after":71750000.0,"shares_owned_after_display":"71,750,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4192708,"accession":"0000919574-25-007187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-007187","line_url":"/filing/0000919574-25-007187#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":1.4325,"price_display":"1.43","price_state":"stated","total_value":214875.0,"total_display":"214,875.00","total_whole":"214,875","shares_owned_after":64200000.0,"shares_owned_after_display":"64,200,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":4978493,"accession":"0000919574-25-007124","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-007124","line_url":"/filing/0000919574-25-007124#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC","owner_display_name":"Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":1.3028,"price_display":"1.30","price_state":"stated","total_value":586260.0,"total_display":"586,260.00","total_whole":"586,260","shares_owned_after":64050000.0,"shares_owned_after_display":"64,050,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-20","scope":"insider"},{"id":4978489,"accession":"0000919574-25-007124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-007124","line_url":"/filing/0000919574-25-007124#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC","owner_display_name":"Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":1.2826,"price_display":"1.28","price_state":"stated","total_value":448910.0,"total_display":"448,910.00","total_whole":"448,910","shares_owned_after":63600000.0,"shares_owned_after_display":"63,600,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-20","scope":"insider"},{"id":4978477,"accession":"0000919574-25-007124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-007124","line_url":"/filing/0000919574-25-007124#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC","owner_display_name":"Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275000.0,"shares_display":"275,000","price_per_share":1.2342,"price_display":"1.23","price_state":"stated","total_value":339405.0,"total_display":"339,405.00","total_whole":"339,405","shares_owned_after":63250000.0,"shares_owned_after_display":"63,250,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-20","scope":"insider"},{"id":4698311,"accession":"0000919574-25-007087","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-007087","line_url":"/filing/0000919574-25-007087#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225000.0,"shares_display":"225,000","price_per_share":1.2248,"price_display":"1.22","price_state":"stated","total_value":275580.0,"total_display":"275,580.00","total_whole":"275,580","shares_owned_after":62975000.0,"shares_owned_after_display":"62,975,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-17","scope":"insider"},{"id":4698305,"accession":"0000919574-25-007087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-007087","line_url":"/filing/0000919574-25-007087#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":1.2392,"price_display":"1.24","price_state":"stated","total_value":309800.0,"total_display":"309,800.00","total_whole":"309,800","shares_owned_after":62750000.0,"shares_owned_after_display":"62,750,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-14","filed_date":"2025-11-17","scope":"insider"},{"id":4698299,"accession":"0000919574-25-007087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-007087","line_url":"/filing/0000919574-25-007087#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":1.2031,"price_display":"1.20","price_state":"stated","total_value":541395.0,"total_display":"541,395.00","total_whole":"541,395","shares_owned_after":62500000.0,"shares_owned_after_display":"62,500,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-17","scope":"insider"},{"id":4192704,"accession":"0000919574-25-006597","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-25-006597","line_url":"/filing/0000919574-25-006597#line-4","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":375000.0,"shares_display":"375,000","price_per_share":1.1889,"price_display":"1.19","price_state":"stated","total_value":445837.5,"total_display":"445,837.50","total_whole":"445,838","shares_owned_after":62050000.0,"shares_owned_after_display":"62,050,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-12","scope":"insider"},{"id":4192696,"accession":"0000919574-25-006597","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-006597","line_url":"/filing/0000919574-25-006597#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":1.196,"price_display":"1.20","price_state":"stated","total_value":358800.0,"total_display":"358,800.00","total_whole":"358,800","shares_owned_after":61675000.0,"shares_owned_after_display":"61,675,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-12","scope":"insider"},{"id":4192689,"accession":"0000919574-25-006597","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-006597","line_url":"/filing/0000919574-25-006597#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275000.0,"shares_display":"275,000","price_per_share":1.1706,"price_display":"1.17","price_state":"stated","total_value":321915.0,"total_display":"321,915.00","total_whole":"321,915","shares_owned_after":61375000.0,"shares_owned_after_display":"61,375,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"},{"id":4192684,"accession":"0000919574-25-006597","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-006597","line_url":"/filing/0000919574-25-006597#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225000.0,"shares_display":"225,000","price_per_share":1.1234,"price_display":"1.12","price_state":"stated","total_value":252765.0,"total_display":"252,765.00","total_whole":"252,765","shares_owned_after":61100000.0,"shares_owned_after_display":"61,100,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-07","filed_date":"2025-11-12","scope":"insider"},{"id":4162318,"accession":"0000919574-25-006180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-006180","line_url":"/filing/0000919574-25-006180#line-1","is_derivative":false,"issuer_cik":"0000834365","issuer_name":"BIOLIFE SOLUTIONS INC","issuer_ticker":"BLFS","issuer_name_source":null,"issuer_url":"/issuer/0000834365","owner_cik":null,"owner_name":"Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Eli","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750000.0,"shares_display":"750,000","price_per_share":28.5471,"price_display":"28.55","price_state":"stated","total_value":21410325.0,"total_display":"21,410,325.00","total_whole":"21,410,325","shares_owned_after":5957165.0,"shares_owned_after_display":"5,957,165","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-17","scope":"insider"},{"id":5022109,"accession":"0000919574-25-005636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-005636","line_url":"/filing/0000919574-25-005636#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.2892,"price_display":"1.29","price_state":"stated","total_value":128920.0,"total_display":"128,920.00","total_whole":"128,920","shares_owned_after":60875000.0,"shares_owned_after_display":"60,875,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-09","filed_date":"2025-09-11","scope":"insider"},{"id":4612851,"accession":"0000919574-25-005603","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-005603","line_url":"/filing/0000919574-25-005603#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":1.2774,"price_display":"1.28","price_state":"stated","total_value":319350.0,"total_display":"319,350.00","total_whole":"319,350","shares_owned_after":60775000.0,"shares_owned_after_display":"60,775,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-05","scope":"insider"},{"id":4612846,"accession":"0000919574-25-005603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-005603","line_url":"/filing/0000919574-25-005603#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":1.2656,"price_display":"1.27","price_state":"stated","total_value":316400.0,"total_display":"316,400.00","total_whole":"316,400","shares_owned_after":60525000.0,"shares_owned_after_display":"60,525,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-05","scope":"insider"},{"id":4192618,"accession":"0000919574-25-005152","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-005152","line_url":"/filing/0000919574-25-005152#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC; Casdin Eli","owner_display_name":"Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":1.2635,"price_display":"1.26","price_state":"stated","total_value":157937.5,"total_display":"157,937.50","total_whole":"157,938","shares_owned_after":60275000.0,"shares_owned_after_display":"60,275,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-26","scope":"insider"},{"id":4192615,"accession":"0000919574-25-005152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-005152","line_url":"/filing/0000919574-25-005152#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC; Casdin Eli","owner_display_name":"Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.2409,"price_display":"1.24","price_state":"stated","total_value":248180.0,"total_display":"248,180.00","total_whole":"248,180","shares_owned_after":60150000.0,"shares_owned_after_display":"60,150,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-26","scope":"insider"},{"id":4370273,"accession":"0000919574-25-005084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-005084","line_url":"/filing/0000919574-25-005084#line-1","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Eli","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":120.9039,"price_display":"120.90","price_state":"stated","total_value":60451950.0,"total_display":"60,451,950.00","total_whole":"60,451,950","shares_owned_after":3007164.0,"shares_owned_after_display":"3,007,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-22","scope":"insider"},{"id":4192610,"accession":"0000919574-25-005152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-005152","line_url":"/filing/0000919574-25-005152#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC; Casdin Eli","owner_display_name":"Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.2634,"price_display":"1.26","price_state":"stated","total_value":252680.0,"total_display":"252,680.00","total_whole":"252,680","shares_owned_after":59950000.0,"shares_owned_after_display":"59,950,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-26","scope":"insider"},{"id":4904502,"accession":"0000919574-25-004979","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-004979","line_url":"/filing/0000919574-25-004979#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":1.2214,"price_display":"1.22","price_state":"stated","total_value":183210.0,"total_display":"183,210.00","total_whole":"183,210","shares_owned_after":59750000.0,"shares_owned_after_display":"59,750,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-15","scope":"insider"},{"id":4871003,"accession":"0000919574-25-005051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-005051","line_url":"/filing/0000919574-25-005051#line-1","is_derivative":false,"issuer_cik":"0000834365","issuer_name":"BIOLIFE SOLUTIONS INC","issuer_ticker":"BLFS","issuer_name_source":null,"issuer_url":"/issuer/0000834365","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":24.4,"price_display":"24.40","price_state":"stated","total_value":12200000.0,"total_display":"12,200,000.00","total_whole":"12,200,000","shares_owned_after":6707165.0,"shares_owned_after_display":"6,707,165","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-21","scope":"insider"},{"id":4904498,"accession":"0000919574-25-004979","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-004979","line_url":"/filing/0000919574-25-004979#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133220.0,"shares_display":"133,220","price_per_share":1.2126,"price_display":"1.21","price_state":"stated","total_value":161542.572,"total_display":"161,542.57","total_whole":"161,543","shares_owned_after":59600000.0,"shares_owned_after_display":"59,600,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-14","filed_date":"2025-08-15","scope":"insider"},{"id":4904494,"accession":"0000919574-25-004979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-004979","line_url":"/filing/0000919574-25-004979#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":1.3104,"price_display":"1.31","price_state":"stated","total_value":98280.0,"total_display":"98,280.00","total_whole":"98,280","shares_owned_after":59466780.0,"shares_owned_after_display":"59,466,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-15","scope":"insider"},{"id":5022102,"accession":"0000919574-25-004702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-004702","line_url":"/filing/0000919574-25-004702#line-1","is_derivative":false,"issuer_cik":"0000834365","issuer_name":"BIOLIFE SOLUTIONS INC","issuer_ticker":"BLFS","issuer_name_source":null,"issuer_url":"/issuer/0000834365","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Eli","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":22.6,"price_display":"22.60","price_state":"stated","total_value":11300000.0,"total_display":"11,300,000.00","total_whole":"11,300,000","shares_owned_after":7207165.0,"shares_owned_after_display":"7,207,165","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-13","scope":"insider"},{"id":4789209,"accession":"0000919574-25-003572","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-003572","line_url":"/filing/0000919574-25-003572#line-1","is_derivative":false,"issuer_cik":"0000834365","issuer_name":"BIOLIFE SOLUTIONS INC","issuer_ticker":"BLFS","issuer_name_source":null,"issuer_url":"/issuer/0000834365","owner_cik":null,"owner_name":"Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC","owner_display_name":"Casdin Eli","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":23.8,"price_display":"23.80","price_state":"stated","total_value":23800000.0,"total_display":"23,800,000.00","total_whole":"23,800,000","shares_owned_after":7707165.0,"shares_owned_after_display":"7,707,165","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-10","filed_date":"2025-06-12","scope":"insider"},{"id":4657646,"accession":"0000919574-25-001777","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-25-001777","line_url":"/filing/0000919574-25-001777#line-4","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4820959.0,"shares_display":"4,820,959","price_per_share":1.065,"price_display":"1.06","price_state":"stated","total_value":5134321.335,"total_display":"5,134,321.34","total_whole":"5,134,321","shares_owned_after":58846780.0,"shares_owned_after_display":"58,846,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-04","scope":"insider"},{"id":2976271,"accession":"0000919574-24-005134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-005134","line_url":"/filing/0000919574-24-005134#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":2.187,"price_display":"2.19","price_state":"stated","total_value":546750.0,"total_display":"546,750.00","total_whole":"546,750","shares_owned_after":54025821.0,"shares_owned_after_display":"54,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-29","scope":"insider"},{"id":2300369,"accession":"0000919574-24-004878","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-004878","line_url":"/filing/0000919574-24-004878#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_display_name":"Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":2.1497,"price_display":"2.15","price_state":"stated","total_value":322455.0,"total_display":"322,455.00","total_whole":"322,455","shares_owned_after":53775821.0,"shares_owned_after_display":"53,775,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-26","scope":"insider"},{"id":2300365,"accession":"0000919574-24-004878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004878","line_url":"/filing/0000919574-24-004878#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_display_name":"Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":292100.0,"shares_display":"292,100","price_per_share":2.1259,"price_display":"2.13","price_state":"stated","total_value":620975.39,"total_display":"620,975.39","total_whole":"620,975","shares_owned_after":53625821.0,"shares_owned_after_display":"53,625,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-26","scope":"insider"},{"id":2300361,"accession":"0000919574-24-004878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004878","line_url":"/filing/0000919574-24-004878#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_display_name":"Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":307900.0,"shares_display":"307,900","price_per_share":1.9578,"price_display":"1.96","price_state":"stated","total_value":602806.62,"total_display":"602,806.62","total_whole":"602,807","shares_owned_after":53333721.0,"shares_owned_after_display":"53,333,721","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-26","scope":"insider"},{"id":2138859,"accession":"0000919574-24-004812","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-004812","line_url":"/filing/0000919574-24-004812#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.9039,"price_display":"1.90","price_state":"stated","total_value":951950.0,"total_display":"951,950.00","total_whole":"951,950","shares_owned_after":53025821.0,"shares_owned_after_display":"53,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-21","scope":"insider"},{"id":2138856,"accession":"0000919574-24-004812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004812","line_url":"/filing/0000919574-24-004812#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.8734,"price_display":"1.87","price_state":"stated","total_value":936700.0,"total_display":"936,700.00","total_whole":"936,700","shares_owned_after":52525821.0,"shares_owned_after_display":"52,525,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-21","scope":"insider"},{"id":2138853,"accession":"0000919574-24-004812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004812","line_url":"/filing/0000919574-24-004812#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":1.8529,"price_display":"1.85","price_state":"stated","total_value":463225.0,"total_display":"463,225.00","total_whole":"463,225","shares_owned_after":52025821.0,"shares_owned_after_display":"52,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-21","scope":"insider"},{"id":2233686,"accession":"0000919574-24-004802","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004802","line_url":"/filing/0000919574-24-004802#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Capital, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200000.0,"shares_display":"1,200,000","price_per_share":1.5946,"price_display":"1.59","price_state":"stated","total_value":1913520.0,"total_display":"1,913,520.00","total_whole":"1,913,520","shares_owned_after":51775821.0,"shares_owned_after_display":"51,775,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-16","scope":"insider"},{"id":3246153,"accession":"0000919574-24-004593","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-004593","line_url":"/filing/0000919574-24-004593#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550000.0,"shares_display":"550,000","price_per_share":1.6192,"price_display":"1.62","price_state":"stated","total_value":890560.0,"total_display":"890,560.00","total_whole":"890,560","shares_owned_after":50575821.0,"shares_owned_after_display":"50,575,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-13","scope":"insider"},{"id":3246149,"accession":"0000919574-24-004593","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004593","line_url":"/filing/0000919574-24-004593#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.6412,"price_display":"1.64","price_state":"stated","total_value":820600.0,"total_display":"820,600.00","total_whole":"820,600","shares_owned_after":50025821.0,"shares_owned_after_display":"50,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-13","scope":"insider"},{"id":3246145,"accession":"0000919574-24-004593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004593","line_url":"/filing/0000919574-24-004593#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":525408.0,"shares_display":"525,408","price_per_share":1.6149,"price_display":"1.61","price_state":"stated","total_value":848481.3792,"total_display":"848,481.38","total_whole":"848,481","shares_owned_after":49525821.0,"shares_owned_after_display":"49,525,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-09","filed_date":"2024-08-13","scope":"insider"},{"id":3246141,"accession":"0000919574-24-004339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004339","line_url":"/filing/0000919574-24-004339#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.","owner_display_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":569562.0,"shares_display":"569,562","price_per_share":1.6374,"price_display":"1.64","price_state":"stated","total_value":932600.8188,"total_display":"932,600.82","total_whole":"932,601","shares_owned_after":49000413.0,"shares_owned_after_display":"49,000,413","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-08","filed_date":"2024-08-09","scope":"insider"}],"collapsed":true,"next_cursor":"2024-08-08|3246141","ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001818331","name":"GeneDx Holdings Corp.","url":"/issuer/0001818331","role":"Director, Ten percent owner","n_filings":10,"first_seen":"2022-05-03","last_seen":"2026-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0000834365","name":"BIOLIFE SOLUTIONS INC","url":"/issuer/0000834365","role":"Ten percent owner","n_filings":14,"first_seen":"2019-11-21","last_seen":"2026-05-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001162194","name":"STANDARD BIOTOOLS INC.","url":"/issuer/0001162194","role":"Director, Ten percent owner","n_filings":22,"first_seen":"2023-05-19","last_seen":"2025-12-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001860782","name":"2seventy bio, Inc.","url":"/issuer/0001860782","role":"Director","n_filings":2,"first_seen":"2024-03-25","last_seen":"2024-03-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001858848","name":"Tenaya Therapeutics, Inc.","url":"/issuer/0001858848","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2021-08-04","last_seen":"2022-11-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001287098","name":"MAXCYTE, INC.","url":"/issuer/0001287098","role":"Ten percent owner","n_filings":3,"first_seen":"2021-08-03","last_seen":"2022-10-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001672688","name":"Absci Corp","url":"/issuer/0001672688","role":"Director","n_filings":1,"first_seen":"2021-07-28","last_seen":"2021-07-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001850119","name":"Century Therapeutics, Inc.","url":"/issuer/0001850119","role":"Director","n_filings":1,"first_seen":"2021-06-22","last_seen":"2021-06-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001733294","name":"Generation Bio Co.","url":"/issuer/0001733294","role":"Ten percent owner","n_filings":1,"first_seen":"2020-06-18","last_seen":"2020-06-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001680581","name":"Fulcrum Therapeutics, Inc.","url":"/issuer/0001680581","role":"Ten percent owner","n_filings":1,"first_seen":"2019-07-22","last_seen":"2019-07-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001434418","name":"CONSTELLATION PHARMACEUTICALS INC","url":"/issuer/0001434418","role":"Ten percent owner","n_filings":1,"first_seen":"2018-07-23","last_seen":"2018-07-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001534264","retrieved_at":"2026-08-24T20:22:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}